Fast and Slow Metabolizers of Hoasca

@article{Callaway2005FastAS,
  title={Fast and Slow Metabolizers of Hoasca},
  author={James C. Callaway},
  journal={Journal of Psychoactive Drugs},
  year={2005},
  volume={37},
  pages={157 - 161}
}
  • J. Callaway
  • Published 2005
  • Medicine
  • Journal of Psychoactive Drugs
Abstract Harmine, a major alkaloid in ayahuasca (hoasca), is a selective and reversible inhibitor of the enzyme monoamine oxidase-A (MAO-A). It is also a selective inhibitor of the human cytochrome P450 isozyme 2D6 (CYP 2D6), which metabolizes harmine to a more hydrophilic derivative for eventual excretion. CYP 2D6 exhibits a wide range of polymorphisms in human populations, and variations in this enzymatic activity could account for differences in effects between individuals who use hoasca… Expand
Indolealkylamines: Biotransformations and Potential Drug–Drug Interactions
  • A. Yu
  • Biology, Medicine
  • The AAPS Journal
  • 2008
TLDR
An important role for polymorphic cytochrome P450 2D6 (CYP2D 6) in the metabolism of IAA drugs of abuse has been revealed by recent studies, suggesting that variations in IAA metabolism, pharmaco- or toxicokinetics and dynamics can arise from distinct CYP2D6 status, and CYP1D6 polymorphism may represent an additional risk factor in the use of these IAAdrugs. Expand
Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model.
TLDR
The findings suggest that distinct CYP2D6 status may cause considerable variations in harmaline metabolism, PK and PD, and that the pharmacogenetics-based PK model may be extended to define PK difference caused by other polymorphic drug-metabolizing enzyme in different populations. Expand
Determination of dimethyltryptamine and β-carbolines (ayahuasca alkaloids) in plasma samples by LC-MS/MS.
TLDR
The method proved to be simple, rapid and useful to estimate administered doses for further pharmacological and toxicological investigations of ayahuasca exposure and improved at the lower end of the calibration curve. Expand
Safety and side effects of ayahuasca in humans--an overview focusing on developmental toxicology.
TLDR
Researchers must take caution when extrapolating nonhuman data to humans and more data are needed in basic and human research before a definite opinion can be made regarding the possible toxic effects of ayahuasca in pregnant women and in their children. Expand
Safety and Side Effects of Ayahuasca in Humans—An Overview Focusing on Developmental Toxicology
TLDR
An overview of the risks and possible toxic effects of ayahuasca in humans is done, reviewing studies on the acute ayahuaco administration to humans, on the possible risks associated with long-term consumption by adults and adolescents, and on the possibly toxic effects on pregnant animals and in their offspring. Expand
Safety and Side Effects of Ayahuasca in Humans—An Overview Focusing on Developmental Toxicology
Abstract Despite being relatively well studied from a botanical, chemical, and (acute) pharmacological perspective, little is known about the possible toxic effects of ayahuasca (an hallucinogenicExpand
A Critical Evaluation of Reports Associating Ayahuasca with Life-Threatening Adverse Reactions
TLDR
It is suggested that previous cardiac and hepatic pathologies and current use of serotonergic drugs/medications are contraindications to ayahuasca use, and that caution should be taken when using different botanical species and extracted/synthetic alkaloids to prepareAyahuasca analogues. Expand
Ayahuasca - potential therapeutic properties in psychiatry. Research review.
TLDR
The complex profile of action and the resulting potential benefits, but also the risk of interaction and adverse effects associated with the taking of ayahuasca are explained, which is important given the high variability of herbal mixtures used to produce the decoction. Expand
A Critical Evaluation of Reports Associating Ayahuasca with Life-Threatening Adverse Reactions
TLDR
A critical evaluation of reports associated with ayahuasca or some of its alkaloids with severe intoxications suggests that previous cardiac and hepatic pathologies and current use of serotonergic drugs/medications are contraindications to a... Expand
The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro
TLDR
It is reported that harmine, tetrahydroharmine and harmaline, the three main alkaloids present in B. caapi, and the harmine metabolite harmol, stimulate adult neurogenesis in vitro, suggesting that modulation of brain plasticity could be a major contribution to the antidepressant effects of ayahuasca. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 31 REFERENCES
Polymorphic Cytochrome P450 2D6: Humanized Mouse Model and Endogenous Substrates
TLDR
Endogenous 5‐methoxyindolethylamines derived from 5‐hydroxytryptamine were identified as high‐affinity substrates of CYP2D6 that catalyzes their O‐demethylations with high enzymatic capacity and specificity, indicating a crucial step in a serotonin‐melatonin cycle. Expand
Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca.
TLDR
The one-step extraction method for DMT and the protein precipitation method for the three harmala alkaloid afford rapid, sensitive, and quantitative analyses of these alkaloids with minimal analyte loss. Expand
Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics
TLDR
Drug administration increased urinary normetanephrine excretion, but, contrary to the typical MAO-inhibitor effect profile, deaminated monoamine metabolite levels were not decreased, suggesting a predominantly peripheral (gastrointestinal and liver) site of action for harmine. Expand
Contribution of Individual Cytochrome P450 Isozymes to theO-Demethylation of the Psychotropic β-Carboline Alkaloids Harmaline and Harmine
TLDR
Inhibition studies using monoclonal antibodies confirmed that CYP1A2 and CYP2D6 were the major isozymes contributing to both harmaline and harmine O-demethylase activities as compared with wild-type mice, and suggest a role for polymorphic CYP 2D6 in the pharmacology and toxicology of harmine and harmaline. Expand
Cytochrome P450 Phenotyping/Genotyping in Patients Receiving Antipsychotics
  • M. Dahl
  • Biology, Medicine
  • Clinical pharmacokinetics
  • 2002
TLDR
The current rapid developments in molecular genetic methodology and pharmacogenetic knowledge can in the near future be expected to provide new tools for prediction of the activity of the various drugmetabolising enzymes. Expand
POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN
TLDR
Family studies supported the view that alicyclic 4-hydroxylation of debrisoquine is controlled by a single autosomal gene and that a defect in this metabolic step is caused by a recessive allele. Expand
Inhibition of monoamine oxidase A by beta-carboline derivatives.
TLDR
Harmine, 2-methylharminium, 2,9-dimethylharminum, and harmaline were the most effective inhibitors of the purified MAO A, with low Ki values of 5, 69, 15, and 48 nM, respectively. Expand
CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.
TLDR
Since alleles which encode for no or reduced functioning clearly affect metabolic activity of drugs mediated by CYP2D6, studies are needed in populations in which these alleles play a major role to assure optimal dosing recommendations are based on empirical pharmacogenetics. Expand
Platelet serotonin uptake sites increased in drinkers ofayahuasca
TLDR
The binding of [3H]citalopram to the platelet 5-hydroxytryptamine (5-HT) transporter was measured in a group of healthy male drinkers ofayahuasca, a psychoactive sacrament indigenous to Amazonia, and a group healthy male controls, to suggest a decreased concentration of extracellular 5-HT, or a response to increased production and release of 5- HT. Expand
The karolinska cocktail for phenotyping of five human cytochrome P450 enzymes
TLDR
Whether the drugs caffeine, losartan, omeprazole, debrisoquin (INN, debrisoquine), and quinine can be given simultaneously in low doses as a cocktail for the phenotyping of cytochrome P450 (CYP) 1A2, 2C9,2C19, 2D6, and 3A4 is determined. Expand
...
1
2
3
4
...